Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
In the context of Biliary tract cancer / Cholangiocarcinoma & Gut microbiota, the swab samples from Biliary tract cancer / Cholangiocarcinoma patients showed significantly lower alfa diversity than those from the controls (pShannon < 0.001)
Proteobacteria was the most commonly found phylum (53%) in the Cholangiocarcinoma (Bile Duct Cancer) patients; Firmicutes (79%) and Actinobacteria (13%) were t…